Phase transition inside the nucleus provides oncogenic function to mutant p53 in cancer

Researchers at the Federal University of Rio de Janeiro (UFRJ), in Brazil, have found a crucial link between phase transition (aggregation) of mutant p53 protein and cancer pathology. The study opens new paths for the development of novels drugs against the disease. The results have been published in advance in the scientific journal Chemical Science.